RevMed
Home/Specialty/Other/System, Test, Tumor Marker, For Detection Of Bladder Cancer/NMP22 BladderChek Test

Alere Scarborough, Inc. D1200 NMP22 BladderChek Test

Company Name
Alere Scarborough, Inc.
Catalog Number
D1200

Description

NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
Have questions or need more information? Contact Us

Pricing
Summary

Price Not Available
Out of Stock
Interested in this product?
Contact us or login to add to your watchlist.

Related Items

57400

NOVA BIOMEDICAL CORPORATION 57400 Stat Profile Prime Plus Blood Gas Analyzer

The Stat Profile Prime Plus Blood Analyzer is a compact, whole blood critical care analyzer that provides rapid and comprehensive results. It measures blood gases, electrolytes, metabolites, and co-oximetry, delivering 32 calculated results. Featuring maintenance-free, replaceable cartridge technology and patented non-lysing co-oximetry, the analyzer produces a complete test panel in about one minute. It also offers bidirectional connectivity and a powerful onboard data management system for efficient data handling and integration
$7,381.36
Clinical Chemistry

Additional Details

Device Identifier
00811877011538
Is RX
Yes
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
No
Is Single Use
Yes

Categories

Barcode Mapping

Unit of MeasurementEachesGTIN
Each100811877011538